View Older Stories

Feb 19, 2026 05:00PM Johnson & Johnson reports positive trial results for head and neck cancer drug

Feb 19, 2026 02:19PM J&J Is Said To Explore $20b-plus Sale Of Orthopedics Unit - Bloomberg

Feb 18, 2026 10:15AM Johnson & Johnson invests over $1 billion in Pennsylvania cell therapy facility

Feb 13, 2026 04:18PM Philadelphia jury awards $250,000 against J&J in baby powder trial

Feb 13, 2026 02:40PM Johnson & Johnson ordered to pay $250,000 in talc powder lawsuit

Feb 13, 2026 02:34PM Pennsylvania jury finds Johnson & Johnson liable for woman's ovarian cancer - Attorney for National Talc Plaintiffs

Feb 9, 2026 04:46AM Johnson & Johnson reports early pilot study results for atrial fibrillation device

Feb 3, 2026 08:51AM Johnson & Johnson (JNJ) PT Raised to $255 at RBC Capital

Jan 30, 2026 10:07AM J&J's AKEEGA gets EU panel backing for prostate cancer expansion

Jan 28, 2026 01:02AM Morgan Stanley Upgrades Johnson & Johnson (JNJ) to Overweight

Jan 27, 2026 03:50PM FDA approves Johnson & Johnson's DARZALEX FASPRO quadruplet for myeloma

Jan 27, 2026 09:38AM Johnson & Johnson (JNJ) PT Raised to $220 at Freedom Capital Markets

Jan 22, 2026 09:07AM 'Johnson & Johnson (JNJ) Well Positioned To Generate Sustained Momentum'; PT Raised at TD Cowen

Jan 22, 2026 08:39AM RBC Capital Defends Johnson & Johnson (JNJ) Amid Talc Concerns

Jan 22, 2026 06:49AM Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ)

Jan 22, 2026 05:16AM Johnson & Johnson (JNJ) PT Raised to $220 at Stifel

Jan 22, 2026 05:12AM Johnson & Johnson (JNJ) PT Raised to $221 at BofA Securities

Jan 22, 2026 05:12AM Johnson & Johnson (JNJ) PT Raised to $221 at BofA Securities

Jan 22, 2026 04:55AM Johnson & Johnson (JNJ) PT Raised to $237 at Raymond James

Jan 21, 2026 08:28AM Johnson & Johnson (JNJ) Meets EPS Estimate, Beats on Revenue; Offers FY Guidance

Jan 21, 2026 04:00AM Oncology, immunology gains to drive J&J Q4 results as investors weigh legal risks

Jan 20, 2026 10:52AM Johnson & Johnson (JNJ) call put ratio 1 call to 1 put into quarter results

Jan 20, 2026 05:10AM Johnson & Johnson (JNJ) call put ratio 2.2 calls to 1 put into quarter results

Jan 14, 2026 04:30PM Johnson & Johnson reports positive results for TECVAYLI in myeloma study

Jan 13, 2026 08:00AM Johnson & Johnson presents depression research at neuroscience meeting

Jan 12, 2026 04:10AM Johnson & Johnson reports extended colorectal cancer study results

Jan 9, 2026 07:46AM HSBC lists 11 potential U.S. outperformers heading into earnings

Jan 9, 2026 07:33AM Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'

Jan 8, 2026 09:25PM Johnson & Johnson (JNJ) Reaches Agreement with U.S. Govt to Lower Drug Costs

Jan 8, 2026 11:15AM Johnson & Johnson (JNJ) call put ratio 2.7 calls more active than puts into the annual J.P. Morgan Healthcare Conference

Jan 8, 2026 07:08AM Lexeo partners with Johnson & Johnson on cardiac gene therapy delivery

Jan 6, 2026 01:37PM Johnson & Johnson (JNJ) PT Raised to $205 at Stifel

Jan 5, 2026 09:16AM UBS Reiterates Buy Rating on Johnson & Johnson (JNJ), Highlights Strong Fundamentals

Dec 31, 2025 12:55PM Goldman Sachs: 'top themes we're tracking for 2026'

Dec 30, 2025 02:15AM Johnson & Johnson (JNJ) PT Raised to $217 at Barclays

Dec 29, 2025 02:35PM BTIG on Apogee (APGE): 'DUPLEX-AD's Failure is Likely a Clearing Event for APG279 and APG777 in Atopic Dermatitis'

Dec 26, 2025 08:05AM Johnson & Johnson ends atopic dermatitis drug trial early over low efficacy

Dec 22, 2025 10:19AM Johnson & Johnson gains European approval for psoriasis drug in children

Dec 19, 2025 02:59PM Trump: Johnson and Johnson and four other companies will be coming in next week, they've agreed to lowest price in world

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 17, 2025 05:27AM Goldman Weekly Options Watch

Dec 16, 2025 04:06PM CFRA Downgrades Johnson & Johnson (JNJ) to Hold

Dec 11, 2025 09:40AM Johnson & Johnson (JNJ) PT Raised to $230; RBC Capital: 'We See Upside'

Dec 9, 2025 12:38PM RBC Capital Defends Legend (LEGN) For Second Day in a Row As Stock Continues to Push Lower

Dec 5, 2025 04:20PM J&J's INLEXZO shows 74% disease-free survival in bladder cancer study

Dec 5, 2025 07:06AM Johnson & Johnson (JNJ) PT Raised to $227 at Guggenheim

Nov 26, 2025 04:02PM Johnson & Johnson (JNJ) tops $500B in valuation

Nov 25, 2025 07:13AM Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ)

Nov 19, 2025 12:50PM FDA grants traditional approval to daratumumab and hyaluronidase-FIHJ for newly diagnosed light chain amyloidosis

Nov 17, 2025 08:05AM Johnson & Johnson reports 48-week data for TREMFYA in psoriatic arthritis

View Older Stories